Replication Of An Early Evaluation Of 30-Day Readmissions Among Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran, Rivaroxaban, Apixaban, or Warfarin In The U.S

CompletedOBSERVATIONAL

Enrollment

14,201

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Atrial Fibrillation

Interventions

DRUG

dabigatran

DRUG

rivaroxaban

DRUG

apixaban

DRUG

warfarin